| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.18 | 6e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.083 | 0.06 |